In the BioHarmony Drug Report Database
Histamine Phosphate, Ceplene (histamine) is a small molecule pharmaceutical. Histamine was first approved as Histamine Phosphate on 1982-01-01. It is used to treat allergic rhinitis seasonal and urticaria in the USA. It has been approved in Europe to treat myeloid leukemia acute. It is known to target histamine H4 receptor, histamine H1 receptor, histamine H3 receptor, carbonic anhydrase 7, histamine H2 receptor, carbonic anhydrase 5A, mitochondrial, carbonic anhydrase 1, and chemotaxis transducer.
Image (chem structure or protein)